Medallion Wealth Advisors’s Core Laboratories CLB Stock Holding History

Medallion Wealth Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30	Closed	-$504	–	1233
2026 Q1	$504	Hold	30	–	–	﹤0.01%	1079
2025 Q4	$481	Hold	30	–	–	﹤0.01%	1081
2025 Q3	$371	Hold	30	–	–	﹤0.01%	1069
2025 Q2	$346	Hold	30	–	–	﹤0.01%	1057
2025 Q1	$450	Hold	30	–	–	﹤0.01%	1027
2024 Q4	$450	Buy	+30	New	+$579	﹤0.01%	972

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Medallion Wealth Advisors's CLB Position: Q2 2026 in Review

Medallion Wealth Advisors sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 30 shares — an estimated $504 sold.

Medallion Wealth Advisors first reported a position in CLB in Q4 2024 and held it in 6 quarters. The position peaked at $504 in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Medallion Wealth Advisors reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
Medallion Wealth Advisors sold 30 Core Laboratories shares in Q2 2026, an estimated $504.
Medallion Wealth Advisors first reported a position in Core Laboratories in Q4 2024 and held it in 6 quarters.
Medallion Wealth Advisors's Core Laboratories position peaked at $504 in Q1 2026.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.